Cytosolic virus detection in Caenorhabditis elegans
秀丽隐杆线虫胞浆病毒检测
基本信息
- 批准号:8824358
- 负责人:
- 金额:$ 23.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-16 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseAnimal ModelAntiviral AgentsAntiviral ResponseBiological ModelsCaenorhabditis elegansDevelopmentDouble-Stranded RNAFamilyFamily memberHumanInvadedLeadLightMammalsMediatingMolecularN-terminalNatural ImmunityNematodaPatternPlayProductionRNA HelicaseRNA InterferenceRNA VirusesRegulationResearchRoleSignal TransductionSignaling MoleculeSpecificityStructureViralViral PathogenesisVirusVirus DiseasesWhole Organismbaseimprovedmembermutantnovelpublic health relevanceresponseviral RNAviral detection
项目摘要
DESCRIPTION (provided by applicant): In mammals, including humans, RIG-I-like RNA helicases (RLHs) RIG-I, MDA5 and LGP2 detect invading viral RNAs thereby to initiate an antiviral signaling cascade. Interestingly, although sharing similar domain structure, RIG-I and MDA5 appear to detect RNA viruses of distinct classes. LGP2 is another type of RLH that lacks the N-terminal domains conserved in RIG-I and MDA5 and is known to play a regulatory role in antiviral signaling initiated by RIG-I and MDA5. Currently, whether additional viral molecular patterns are recognized by RIG-I and MDA5 for efficient virus detection by RIG-I and what determines the virus recognition specificity of RIG-I and MDA5 remain largely unknown. Since current studies on the function and mechanism of LGP2 have been generating controversial findings, as a result, how LGP2 regulates the antiviral signaling initiated by RIG-I and MDA5 remains unclear. Our recent observations suggested that RLHs as a three-member family also play important role in antiviral RNA silencing in the nematode Caenorhabditis elegans. Most importantly, one of the worm RLHs, termed DRH-1, appears to contribute to virus detection in a way similar to virus detection by RIG-I. It was also clear from our study that DRH-3, another C. elegans RLH that shares similar domain structure with DRH-1, plays a distinct role in antiviral RNA silencing. The third C. elegans RLH, termed DRH-2, lacks an N-terminal domain found in DRH-1 and DRH-3 and is known to negatively regulate antiviral RNA silencing. Interestingly, DRH-2 functionally replaces the corresponding domains of DRH-1, suggesting that it may specifically regulate the function of DRH-1 in antiviral RNA silencing. Taken together, these observations together establish C. elegans as an ideal model system to study RLH-mediated virus sensing at whole organism level. To better understand how viruses are detected and destroyed by antiviral RNA silencing in C. elegans, here we propose to (1) elucidate the mechanism of DRH-1 in virus sensing by investigating what DRH-1 detects and how the antiviral signal is transmitted to downstream signaling molecules; (2) elucidate the mechanism controlling the function specificity of DRH-1 and DRH-3 by defining a role of DRH-3 in antiviral silencing and viral pathogenesis; (3) determine if DRH-2 specifically targets and regulates the function of DRH-1. Findings from the proposed studies are also expected to (1) identify novel molecular patterns recognized by RIG-I and MDA5; (2) shed light on the mechanism controlling virus recognition specificity of RIG-I and MDA5; (3) have direct input to input to the study of LGP2-mediated regulation of antiviral signaling initiated by RIG-I and MDA5.
描述(由申请人提供):在包括人类的哺乳动物中,RIG-I样RNA解旋酶(RLHS)RIG-I,MDA5和LGP2检测入侵的病毒RNA,从而启动抗病毒信号传导级联。有趣的是,尽管共享相似的域结构,但RIG-I和MDA5似乎检测了不同类别的RNA病毒。 LGP2是另一种缺乏RIG-I和MDA5中N末端结构域的RLH,众所周知,它在RIG-I和MDA5发起的抗病毒信号中起着调节作用。目前,RIG-I和MDA5是否识别出其他病毒分子模式,以通过RIG-1的有效病毒检测以及确定RIG-I和MDA5病毒识别特异性的有效病毒检测。由于目前对LGP2功能和机制的研究一直在产生有争议的发现,因此,LGP2如何调节RIG-I和MDA5引起的抗病毒信号传导尚不清楚。 我们最近的观察结果表明,RLHS作为一个三成员的家族在线虫秀丽隐杆线虫中的抗病毒RNA沉默中也起着重要作用。最重要的是,称为DRH-1的蠕虫RLH中的一种似乎以类似于RIG-I检测的病毒检测的方式导致病毒检测。从我们的研究中也可以清楚地看出,与DRH-1共享类似域结构的另一位C.秀韧带RLH DRH-3在抗病毒RNA沉默中起着独特的作用。第三枚秀丽隐杆线虫RLH称为DRH-2,缺少在DRH-1和DRH-3中发现的N末端结构域,并且已知会对抗病毒RNA沉默进行负调节。有趣的是,DRH-2在功能上替代了DRH-1的相应域,这表明它可以特别调节DRH-1在抗病毒RNA沉默中的功能。综上所述,这些观察结果共同建立了秀丽隐杆线虫作为一个理想的模型系统,可以研究RLH介导的整个生物水平的病毒感测。 为了更好地了解秀丽隐杆线虫中抗病毒RNA沉默如何检测和破坏病毒,我们在这里提议(1)通过研究DRH-1检测到什么以及如何将抗病毒信号传递到下游信号分子,以阐明病毒传感中DRH-1的机制; (2)通过定义DRH-3在抗病毒沉默和病毒发病机理中的作用来阐明控制DRH-1和DRH-3功能特异性的机制; (3)确定DRH-2是否特异性靶向并调节DRH-1的功能。拟议研究的结果还有望(1)确定由RIG-I和MDA5识别的新型分子模式; (2)阐明了控制RIG-I和MDA5病毒识别特异性的机制; (3)直接输入输入了RIG-I和MDA5引发的LGP2介导的抗病毒信号的调节。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Northern Blot Detection of Virus-Derived Small Interfering RNAs in Caenorhabditis elegans Using Nonradioactive Oligo Probes.
- DOI:10.1007/978-1-4939-7237-1_3
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Tianyun Long;R. Lu
- 通讯作者:Tianyun Long;R. Lu
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rui Lu其他文献
Rui Lu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rui Lu', 18)}}的其他基金
Negative regulation of human antiviral RNAi by PACT
PACT 对人类抗病毒 RNAi 的负调控
- 批准号:
10667112 - 财政年份:2023
- 资助金额:
$ 23.02万 - 项目类别:
MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia
MEF2D 介导的急性髓系白血病转录控制
- 批准号:
10542726 - 财政年份:2021
- 资助金额:
$ 23.02万 - 项目类别:
MEF2D-Mediated Transcriptional Control of Acute Myeloid Leukemia
MEF2D 介导的急性髓系白血病转录控制
- 批准号:
10365298 - 财政年份:2021
- 资助金额:
$ 23.02万 - 项目类别:
In-depth study of antiviral RNA silencing in Caenorhabditis elegans
秀丽隐杆线虫抗病毒RNA沉默的深入研究
- 批准号:
9239852 - 财政年份:2017
- 资助金额:
$ 23.02万 - 项目类别:
In-depth study of antiviral RNA silencing in Caenorhabditis elegans
秀丽隐杆线虫抗病毒RNA沉默的深入研究
- 批准号:
9403202 - 财政年份:2017
- 资助金额:
$ 23.02万 - 项目类别:
The functional role of DRH-1 in RNAi directed viral immunity
DRH-1 在 RNAi 定向病毒免疫中的功能作用
- 批准号:
8242983 - 财政年份:2012
- 资助金额:
$ 23.02万 - 项目类别:
The functional role of DRH-1 in RNAi directed viral immunity
DRH-1 在 RNAi 定向病毒免疫中的功能作用
- 批准号:
8415513 - 财政年份:2012
- 资助金额:
$ 23.02万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 23.02万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 23.02万 - 项目类别:
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
通过靶向溶酶体治疗 COVID-19 的宿主防御小分子开发
- 批准号:
10735492 - 财政年份:2023
- 资助金额:
$ 23.02万 - 项目类别:
Development of antibody drug conjugates as pan-filo antivirals
开发作为泛型抗病毒药物的抗体药物偶联物
- 批准号:
10759731 - 财政年份:2023
- 资助金额:
$ 23.02万 - 项目类别:
Targeting Nuclear HSF1 as a Novel Anti-HCMV Strategy
靶向核 HSF1 作为一种新型抗 HCMV 策略
- 批准号:
10656697 - 财政年份:2023
- 资助金额:
$ 23.02万 - 项目类别: